“…The appropriate techniques for analyzing these and other health interventions are cost-effectiveness analysis (CEA), which compares the incremental economic cost of an intervention to its incremental effectiveness in terms of clinical outcomes of 0740-5472/04/$ -see front matter D 2004 Elsevier Inc. All rights reserved. doi:10.1016/j.jsat.2004.08.005 often intangible value (e.g., Barnett, Zaric, & Brandeau, 2001;Drummond, O'Brien, Stoddart, & Torrance, 1997;Gold, Siegel, Russell, & Weinstein, 1996;McCollister, French, Inciardi, et al, 2003;McCollister, French, Prendergast, et al, 2003;Zarkin, Lindrooth, Demiralp, & Wechsberg, 2001), and benefit-cost analysis (BCA), which accounts for multiple health, criminal justice, and other outcomes of tangible value (French, McCollister, Cacciola, Durell, & Stephens, 2002;French, McCollister, Sacks, McKendrick, & De Leon, 2002;French, Salomé, & Carney, 2002;French et al, 2000;French, Salomé, Sindelar, & McLellan, 2002;Gerstein et al, 1994;Harwood, Hubbard, Collins, & Rachal, 1995;Plotnick, 1994;Rajkumar & French, 1997;Salomé, French, Scott, et al, 2003;Tabbush, 1986). Though often preferred by clinical audiences because of its direct relation to clinical outcomes, CEA can be problematic when used in conjunction with multiple outcomes.…”